Mechanism of Action
Selenium acts through a specific form: selenocysteine, sometimes called the 21st amino acid. The human genetic code reserves a dedicated codon for its insertion into proteins. This specialised machinery reflects the biological importance of the element.
Within the cell, selenoproteins form a coordinated network. Some neutralise peroxides (toxic oxygen derivatives) using glutathione as a substrate. Others regenerate exhausted cellular defences, restoring their protective capacity. This continuous cycle preserves membrane and DNA integrity during every cell division. A third group ensures the conversion of thyroid hormones to their biologically active form.
When intake decreases, the body prioritises. It allocates available selenium first to the brain and endocrine glands. Peripheral tissues are served last. This triage explains why suboptimal status can impair certain functions long before producing visible signs.
Key Benefits
- Strong
A better-supported immune system: selenium contributes to the normal function of the immune system. In 45 British adults, 50 µg per day for four weeks raised antioxidant enzyme activity in lymphocytes and granulocytes.
- Strong
Cells better shielded from oxidative wear: selenium contributes to the protection of cells from oxidative stress. The enzyme rise is greater the lower the baseline activity, and it fades once status is already covered.
- Strong
Thyroid hormones converted to their active form: selenium contributes to the normal thyroid function. The enzymes handling this conversion are selenoproteins, placing the trace element at the heart of basal metabolic regulation.
- Strong
Hair and nails preserved over time: selenium contributes to the maintenance of normal hair and normal nails. The hair follicle, the root of the hair, is among the fast-renewing tissues where selenoproteins are most in demand.
- Strong
A key role in male fertility: selenium contributes to normal spermatogenesis. The testis is the reproductive organ that concentrates the most selenium, a sign of its structural role in sperm maturation.
Dosage & Forms
Three families of forms coexist on the market. Inorganic forms, sodium selenite and sodium selenate, are the least expensive and show limited tissue retention. Selenised yeast provides a spectrum of compounds close to dietary sources, with batch-to-batch variability in composition. L-selenomethionine is a single selenium compound, standardised in selenium, whose content is defined to the microgram.
A British trial compared the two routes at 50 µg per day for four weeks. Both raise the activity of blood glutathione peroxidases, along different time courses.
The adequate intake set in Europe for adults is 70 µg per day. The reference value carried on labels is 55 µg. The European safety limit was revised in 2023: it now stands at 255 µg per day, from all sources combined.
Benefit trials have almost all been run at 200 µg per day, the level at which the first unfavourable signals also appear.
In the Singular Formula
Inclusion rationale
Selenium contributes to the protection of cells from oxidative stress, to the normal function of the immune system, to normal thyroid function and to the maintenance of normal hair and normal nails. The human genome encodes 25 selenoproteins, including glutathione peroxidases (enzymes that neutralize hydrogen peroxide and lipid hydroperoxides) and thioredoxin reductases, involved in regenerating intracellular antioxidant systems. In selenomethionine form, selenium is non-specifically incorporated into body proteins in place of methionine, creating a reservoir mobilizable according to the body's needs. Selenium content in European soils is generally lower than in North American soils, resulting in variable dietary intakes across regions. The deiodinases, enzymes responsible for converting thyroxine (T4) to triiodothyronine (T3, the active form), are themselves selenoproteins. Selenium and iodine (also present in the formula) therefore work in tandem to support normal thyroid function.
Selected form
L-selenomethionine, an organic form of selenium where the selenium atom replaces sulphur in methionine, an essential amino acid. This form exactly replicates the selenium naturally present in food (cereals, Brazil nuts, legumes). Unlike inorganic forms (selenite, selenate), selenomethionine is recognised by intestinal amino acid transporters, providing significantly higher oral bioavailability. Selenium contributes to the normal function of the immune system and to the protection of cells from oxidative stress.
Formula dosage
0 to 100 µg.
Dose expressed as active substance, excluding excipients and carriers of the raw material.
Synergies in the formula
Linked Biomarkers
Safety & Precautions
Selenium has several decades of track record in supplementation. Selenomethionine shows favourable digestive tolerance at nutritional doses.
The European safety limit was lowered to 255 µg per day in 2023, from all dietary and supplementary sources combined. Beyond this threshold, chronic excessive intake can trigger selenosis. It presents as garlic-like breath, brittle nails and hair loss. These signs are reversible upon discontinuation of excessive supplementation.
Selenium supplementation is not recommended for individuals whose serum status is already elevated. A controlled trial in 1,202 adults measured, at 200 µg per day, a rise in type 2 diabetes risk. It was sharpest in participants whose baseline blood selenium was highest. This observation reinforces the relevance of an approach calibrated to individual biological profile.
Pregnant or breastfeeding women should consult a healthcare professional before any supplementation. Documented drug interactions are rare, but selenium may interact with certain medications containing heavy metals.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Vinceti M et al. | 2018 | Meta-analysis | Cochrane Database of Systematic Reviews | View on PubMed |
Selenium for preventing cancer Cochrane systematic review of 83 studies concluding that selenium supplementation does not reduce overall cancer risk, with a signal of increased type 2 diabetes risk at high doses. | ||||
| Rayman MP | 2012 | Review | The Lancet | View on PubMed |
Selenium and human health Landmark review on the biological functions of selenium, the U-shaped dose-response relationship and implications for supplementation. | ||||
| Lippman SM et al. | 2009 | Randomised Controlled Trial | JAMA | View on PubMed |
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) Randomised trial in 35,533 men receiving 200 µg per day of L-selenomethionine. No protection against prostate cancer in men whose status was already adequate. The rise in type 2 diabetes seen in the selenium arm did not reach significance. | ||||
| Jenkins DJA et al. | 2020 | Meta-analysis | The American Journal of Clinical Nutrition | View on PubMed |
Selenium, antioxidants, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials Meta-analysis of 43 randomised trials. Selenium given alone was associated with neither cardiovascular nor all-cause mortality. A reduction appeared only in antioxidant mixtures that included selenium. | ||||
| Rayman MP et al. | 2018 | Randomised Controlled Trial | Free Radical Biology and Medicine | View on PubMed |
Effect of long-term selenium supplementation on mortality: Results from a multiple-dose, randomised controlled trial Danish controlled trial evaluating 100, 200 and 300 µg of selenised yeast over five years, followed by a further ten years. The 300 µg daily dose increased all-cause mortality. The authors conclude that total intake above 300 µg should be avoided. | ||||
| Stranges S et al. | 2007 | Randomised Controlled Trial | Annals of Internal Medicine | View on PubMed |
Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial Post-hoc analysis of the NPC trial showing an association between 200 µg/day selenium supplementation and increased type 2 diabetes risk, mainly in subjects with high baseline status. | ||||
| Hurst R et al. | 2010 | Randomised Controlled Trial | The American Journal of Clinical Nutrition | View on PubMed |
Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial Controlled trial in 119 British adults aged 50 to 64, at 50, 100 or 200 µg per day for twelve weeks. Plasma selenoprotein P rose at every dose, and 50 µg sufficed to optimise it. Platelet glutathione peroxidase activity, by contrast, did not change at any dose. | ||||
| Brown KM et al. | 2000 | Randomised Controlled Trial | Clinical Science | View on PubMed |
Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes Controlled trial in 45 British adults comparing selenomethionine and sodium selenite, at 50 µg per day for twenty-eight days. Glutathione peroxidase activity rose in both groups, the more so where baseline activity was low. | ||||